Geron Corp (NASDAQ: GERN) kicked off on Tuesday, down -3.15% from the previous trading day, before settling in for the closing price of $1.27. Over the past 52 weeks, GERN has traded in a range of $1.04-$4.09.
Annual sales at Healthcare sector company grew by 5.60% over the past five years. While this was happening, its average annual earnings per share was recorded 61.11%. With a float of $607.28 million, this company’s outstanding shares have now reached $638.36 million.
Let’s look at the performance matrix of the company that is accounted for 229 employees.
Geron Corp (GERN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 4.87%, while institutional ownership is 75.55%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.04 earnings per share (EPS), higher than consensus estimate (set at -0.05) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.11% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 4.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 5.39 million, a negative change from its year-to-date volume of 10.9 million. As of the previous 9 days, the stock’s Stochastic %D was 64.23%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 37.25%, which indicates a significant decrease from 56.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0558 in the past 14 days, which was lower than the 0.0701 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2284, while its 200-day Moving Average is $1.3810. Nevertheless, the first resistance level for the watch stands at $1.2583 in the near term. At $1.2867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3033. If the price goes on to break the first support level at $1.2133, it is likely to go to the next support level at $1.1967. Assuming the price breaks the second support level, the third support level stands at $1.1683.
Geron Corp (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 785.18 million has total of 638,355K Shares Outstanding. Its annual sales at the moment are 76,990 K in contrast with the sum of -174,570 K annual income. Company’s last quarter sales were recorded 47,230 K and last quarter income was -18,430 K.
